CN118121465A - Rheumatoid arthritis treatment device - Google Patents
Rheumatoid arthritis treatment device Download PDFInfo
- Publication number
- CN118121465A CN118121465A CN202410241293.6A CN202410241293A CN118121465A CN 118121465 A CN118121465 A CN 118121465A CN 202410241293 A CN202410241293 A CN 202410241293A CN 118121465 A CN118121465 A CN 118121465A
- Authority
- CN
- China
- Prior art keywords
- treatment
- drug
- analysis module
- user
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000011282 treatment Methods 0.000 title claims abstract description 127
- 206010039073 rheumatoid arthritis Diseases 0.000 title claims abstract description 41
- 230000017531 blood circulation Effects 0.000 claims abstract description 68
- 239000008280 blood Substances 0.000 claims abstract description 54
- 210000004369 blood Anatomy 0.000 claims abstract description 54
- 238000012544 monitoring process Methods 0.000 claims abstract description 52
- 230000009471 action Effects 0.000 claims abstract description 12
- 239000003814 drug Substances 0.000 claims description 98
- 229940079593 drug Drugs 0.000 claims description 81
- 239000010410 layer Substances 0.000 claims description 69
- 230000001225 therapeutic effect Effects 0.000 claims description 29
- 238000012377 drug delivery Methods 0.000 claims description 15
- 230000005855 radiation Effects 0.000 claims description 15
- 238000010438 heat treatment Methods 0.000 claims description 12
- 230000000004 hemodynamic effect Effects 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 8
- 238000012806 monitoring device Methods 0.000 claims description 5
- 239000002344 surface layer Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 19
- 238000000034 method Methods 0.000 description 8
- 230000002792 vascular Effects 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010061619 Deformity Diseases 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003108 foot joint Anatomy 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 210000002478 hand joint Anatomy 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000002078 massotherapy Methods 0.000 description 1
- 210000000811 metacarpophalangeal joint Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000009097 single-agent therapy Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 238000000015 thermotherapy Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Radiation-Therapy Devices (AREA)
Abstract
The invention discloses a rheumatoid arthritis treatment device, which relates to the technical field of treatment instruments and comprises an analysis module and a treatment assembly; the treatment assembly comprises a plurality of treatment units which independently operate and a blood flow dynamic monitoring piece, wherein the blood flow dynamic monitoring piece is attached to the body surface of a user, and blood parameters of the user are acquired in a non-invasive manner in real time; the analysis module receives the user blood parameters acquired by the blood flow dynamic monitoring part in real time, and according to the received user blood parameters, the analysis module invokes the operation parameters of each treatment unit in the operation parameter set, and according to the operation parameters matched with the execution assignment, the analysis module controls the execution of the actions of each treatment unit. The rheumatoid arthritis treatment device can be used for pertinently matching the working states of all treatment units according to the blood flow condition of the affected part of the user, and matching a treatment scheme with pertinence clinical treatment practice for the user, so that the user can obtain a better treatment effect.
Description
Technical Field
The invention relates to the technical field of therapeutic instruments, in particular to a rheumatoid arthritis therapeutic device.
Background
Rheumatoid arthritis belongs to a chronic autoimmune disease. After the user suffers from illness, more typical symptoms can appear on joints and the whole body, such as metacarpophalangeal joint pain, swelling and deformity, general discomfort, anorexia, fever and the like. Rheumatoid arthritis has higher disability rate, and no specific therapy exists at present.
For rheumatoid arthritis, western medicine is taken orally as main treatment method, and common medicines include non-steroidal anti-inflammatory drugs, glucocorticoid and the like. Although the medicines take effect rapidly, the pain feeling of the user can be relieved in a short period, the further development of the illness state is controlled, but the long-term taking of the medicines can increase the burden of organs such as liver and kidney, but can increase the burden of long-term treatment of the user, and the user has higher recurrence probability after stopping the medicines. In terms of traditional Chinese medicine, rheumatoid arthritis belongs to the category of arthralgia syndrome, and has the disease names of arthritis, crane-knee wind, stubborn arthralgia and the like, wherein the internal cause of the disease is deficiency of healthy qi, and the external cause is invasion of exogenous pathogenic factors such as wind, cold, dampness and the like. The traditional Chinese medicine is used for treating the rheumatoid arthritis, generally after differentiation of symptoms and types, a treatment scheme of mutually matching a plurality of methods such as external use of traditional Chinese medicines, acupuncture, moxibustion and the like is selected, and the traditional Chinese medicine has the advantages of good curative effect, small toxic and side effects and the like, and clinically achieves satisfactory curative effect.
At present, most of the therapeutic apparatuses for rheumatoid arthritis only have the function of implementing single traditional Chinese medicine therapy, such as thermal therapy, hot compress and the like, and the existing therapeutic apparatuses generally have the function of adjusting the output power of the apparatus or the working time of the apparatus, so that the therapeutic effect is relatively limited, and the user is difficult to carry out targeted therapy according to the own affected part condition.
Disclosure of Invention
The invention aims to provide a rheumatoid arthritis treatment device which is used for solving the problems that the existing treatment instrument can only implement monotherapy and a user is difficult to carry out targeted treatment according to the situation of the affected part by acquiring the blood situation of the affected part of the user and matching a comprehensive treatment scheme for the user according to the blood situation of the affected part of the user.
In order to achieve the above purpose, the present invention adopts the following technical scheme:
a rheumatoid arthritis treatment device comprising an analysis module and a treatment assembly; wherein,
The treatment assembly comprises a plurality of independently operated treatment units and a blood flow dynamic monitoring member,
Each treatment unit is connected with the analysis module and executes treatment action based on the operation parameters set by the analysis module;
The blood flow dynamic monitoring piece is connected with the analysis module and is attached to the body surface of the user, so that the blood parameters of the user are obtained in real time in a non-invasive mode;
the operation parameter set of each treatment unit is pre-constructed in the analysis module, the operation parameters associated with the treatment units are set in the operation parameter set of each treatment unit, and a plurality of execution assignment values are pre-set for the operation parameters;
The analysis module receives the user blood parameters acquired by the blood flow dynamic monitoring part in real time, and according to the received user blood parameters, the analysis module invokes the operation parameters of each treatment unit in the operation parameter set, matches corresponding execution assignment values for each operation parameter, and controls the action execution of each treatment unit according to the matched execution assignment operation parameters.
In some embodiments, the analysis module invokes the operating parameters of each treatment unit paired one-to-one with the execution assignment to generate a plurality of operating parameter sets; the blood flow dynamic monitoring part acquires a plurality of blood parameters of a user in real time and uploads the blood parameters to the analysis module, such as blood flow velocity, pulse waveform, blood flow, vascular resistance, blood sample saturation and other blood parameters; the analysis module acquires a plurality of blood parameters, respectively judges whether each blood parameter meets preset conditions, gives a corresponding judgment mark to each blood parameter data based on the judgment result of each blood parameter, and matches and selects an operation parameter set based on the set information formed by a plurality of judgment marks; the analysis module controls the treatment action of each treatment unit to be executed according to the matched and selected operation parameter set.
According to clinical treatment experience, a plurality of operation parameter sets can be pre-generated in the analysis module, and the operation parameter sets can provide a treatment method with clinical treatment practice for the rheumatoid arthritis treatment device, for example, according to clinical treatment experience, the execution assignment of the operation parameter, namely a specific temperature value, of the operation temperature of the treatment unit is preset, and the operation parameter is combined with the operation parameter set of the associated execution assignment to generate an operation parameter set.
After a plurality of operation parameter sets are pre-generated in the analysis module, the rheumatoid arthritis treatment device monitors the condition of the affected part of the user through the blood flow dynamic monitoring piece, and can match a treatment scheme with clinical treatment practice for the user according to the condition of the affected part of the user, so that the user obtains a better treatment effect.
In some embodiments, the treatment unit may be a far infrared module, where the far infrared module includes a far infrared radiation lamp capable of adjusting a distance between the far infrared radiation lamp and the body surface of the user, and a far infrared control module for adjusting irradiation time and irradiation frequency is disposed in the far infrared radiation lamp, and the far infrared control module is connected with the analysis module.
The far infrared radiation lamp has longer-wavelength infrared rays, can penetrate into the deep skin of an affected part, generates a warm effect, and generates various physiological effects on human tissues. For rheumatoid arthritis users, the far infrared treatment system has the functions of relieving pain and inflammation, improving joint mobility, promoting tissue repair and rehabilitation and the like.
In some embodiments, the treatment unit may be a directional drug delivery module, as well as a mild moxibustion massage module, wherein,
The directional drug permeation module comprises a drug permeation layer which can be attached to the surface layer of the skin of an affected part, an electrode plate is wrapped in the drug permeation layer, a drug delivery component for delivering liquid medicine is connected to the drug permeation layer, and the electrode plate and the drug delivery component are connected with the analysis module;
the warm moxibustion massage module comprises a massage layer which can be pressed on the skin surface layer of an affected part, wherein a vibration element for vibrating the massage layer and a heating element for heating the massage layer are arranged in the massage layer.
In some embodiments, the drug delivery assembly comprises a plurality of drug cartridges for storing the drug solution, drug solution conduits connected in one-to-one correspondence with the drug cartridges, a delivery power source for drawing the drug solution, and a drug permeable layer, the delivery power source is connected with the analysis module, and the drug solution conduits are collectively connected to the delivery power source and are connected to the drug permeable layer via the delivery power source.
In some embodiments, the massage layer includes a plurality of balls, each ball having a vibrating element and a heating element disposed therein, such that each ball is capable of vibrating and heating individually.
In some embodiments, the therapeutic assembly comprises a flexibly deformable substrate, the hemodynamic monitoring element is disposed at one end of the substrate, the drug permeable layer and the massage layer are disposed at the same end of the substrate around the hemodynamic monitoring element, and the drug permeable layer and the massage layer are spaced apart around the hemodynamic monitoring element.
In some embodiments, the massage layer further comprises a plurality of flexibly deformable support blocks disposed at an end of the base body where the hemodynamic monitoring element is disposed and protruding from an outer surface of the base body, each ball being respectively embedded in a corresponding support block, an outer surface portion of the ball protruding out of the support block.
In some embodiments, a cavity is provided in the matrix into which the drug-permeable layer is embedded; the blood flow dynamic monitoring device comprises a basal body, a blood flow dynamic monitoring part, a cavity, a limiting block and a blood flow dynamic monitoring part, wherein the basal body is provided with one end of the blood flow dynamic monitoring part, the cavity is provided with an opening communicated with the outside, and the limiting block is arranged around the opening and extends towards the center of the opening; the drug permeable layer is embedded into the cavity through the opening and is abutted on the limiting block.
Compared with the prior art, the rheumatoid arthritis treatment device has the beneficial effects that:
(1) The rheumatoid arthritis treatment device can pertinently match the working state of each treatment unit according to the blood flow condition of the affected part of the user, and a treatment scheme with pertinence clinical treatment practice is matched for the user, so that the user can obtain a better treatment effect;
(2) The blood flow dynamic monitoring piece of the rheumatoid arthritis treatment device monitors the blood flow condition of the affected part of the user in a non-invasive mode, the limb of the user can move freely in the treatment process, the invasive damage to the user can not be caused, and the use is more convenient;
(3) The rheumatoid arthritis treatment device combines the far infrared module, the directional drug permeation module and the warm moxibustion massage module, applies comprehensive treatment to the affected part of the user in multiple modes, and has more comprehensive treatment effect.
Drawings
FIG. 1 is a schematic view of a rheumatoid arthritis therapeutic apparatus according to an embodiment of the present invention;
FIG. 2 is a schematic view of a treatment ring in an embodiment of the present invention;
FIG. 3 is a schematic cross-sectional view of a cavity according to an embodiment of the present invention;
FIG. 4 is a flow chart of an analysis module making a determination based on blood parameters in an embodiment of the invention;
FIG. 5 is a schematic diagram showing connection of analysis modules in an embodiment of the present invention.
In the figure, 1, a shell; 2. an analysis module; 3. a blood flow dynamic monitoring member; 4. a far infrared module; 40. a far infrared radiation lamp; 5. a directional drug permeation module; 50. a drug permeable layer; 51. a drug delivery assembly; 510. a medicine box; 6. a warm moxibustion massage module; 60. a massage layer; 600. a ball; 601. a support block; 7. a base; 70. avoiding a cavity; 700. an opening; 701. and a limiting block.
Detailed Description
The following describes in further detail the embodiments of the present invention with reference to the drawings and examples. The following examples are illustrative of the invention and are not intended to limit the scope of the invention.
In the description of the present invention, it will be understood that when an element is referred to as being "fixed" or "disposed" on another element, it can be directly on the other element or be indirectly on the other element. When an element is referred to as being "connected to" another element, it can be directly connected to the other element or be indirectly connected to the other element. The terms "mounted," "connected," "coupled," and "connected" are to be construed broadly, and may be, for example, fixedly connected, detachably connected, or integrally connected; can be mechanically or electrically connected; can be directly connected or indirectly connected through an intermediate medium, and can be communicated with the inside of two elements or the interaction relationship of the two elements. The specific meaning of the above terms in the present invention can be understood by those of ordinary skill in the art according to the specific circumstances.
In the description of the present invention, it should be understood that the terms "height," "upper," "lower," "vertical," "horizontal," "top," "bottom," "inner," "outer," and the like are used herein with respect to the orientation or positional relationship shown in the drawings merely to facilitate describing the invention and simplify the description, but do not indicate or imply that the devices or elements referred to must have a particular orientation, be constructed and operate in a particular orientation, and thus should not be construed as limiting the invention.
In the description of the present invention, it should be understood that the terms "first," "second," and the like are used herein for descriptive purposes only and are not to be construed as indicating or implying a relative importance or an implicit indication of the number of features being indicated. Thus, a feature defining "a first" or "a second" may explicitly or implicitly include one or more such feature.
Examples
As shown in fig. 1 to 5, a rheumatoid arthritis therapeutic apparatus according to a preferred embodiment of the present invention includes a housing 1, an analysis module 2 is disposed in the housing 1, and a therapeutic component is disposed outside the housing 1, where the analysis module 2 is an automatic controller such as a PID controller, a data processor, etc. and is configured to control the therapeutic component to perform a therapeutic action.
The treatment assembly may comprise a plurality of independently operated treatment units, and hemodynamic monitoring member 3. In this embodiment, the treatment component includes a far infrared module 4, a directional drug-permeable module 5, and a warm moxibustion massage module 6, where the far infrared module 4, the directional drug-permeable module 5, and the warm moxibustion massage module 6 are all treatment units that can operate independently, are connected to the analysis module 2, and perform treatment actions based on the operation parameters set by the analysis module 2.
The blood flow dynamic monitoring member 3 is connected with the analysis module 2, and the blood flow dynamic monitoring member 3 is attached to the body surface of the user, so as to obtain the blood flow condition in the user in real time in a non-invasive manner, especially the blood flow condition of the affected part of the user, such as blood flow velocity, pulse waveform, blood flow, vascular resistance, blood sample saturation and other blood parameters. Specifically, the blood flow dynamic detection piece is a patch which can be attached to the surface layer of skin, and by printing a chemical electrode, an ultrasonic transducer and a sensor on the patch, the ultrasonic transducer is applied with voltage based on the chemical electrode, so that the ultrasonic transducer sends ultrasonic waves to a user, and when the ultrasonic waves rebound from an artery, the sensor detects the rebound ultrasonic waves and converts signals into readings of blood parameters. By configuring sensors of different functions on the patch, the sensors detect the rebounded ultrasonic waves, and can convert the signals into corresponding blood parameters.
The blood flow dynamic monitoring device 3 is connected to the analysis module 2, and may be realized by providing a connection circuit between the blood flow dynamic monitoring device 3 and the analysis module 2, so that the blood flow dynamic monitoring device 3 may transmit the acquired blood parameters to the analysis module 2.
In the rheumatoid arthritis treatment device, an operation parameter set of each treatment unit is pre-built in an analysis module 2 serving as an automatic controller, operation parameters associated with the treatment units are set in the operation parameter set of each treatment unit, and a plurality of execution assignments are pre-set for the operation parameters. When executing treatment, the analysis module 2 receives the blood parameters of the user acquired by the blood flow dynamic monitoring piece 3 in real time, and according to the received blood parameters of the user, the analysis module 2 invokes the operation parameters of each treatment unit in the operation parameter set, matches corresponding execution assignment values for each operation parameter, and controls the action execution of each treatment unit according to the matched execution assignment operation parameters.
By monitoring the condition of blood flow near the affected part of the user, the analysis module 2 can judge the inflammation degree and the activity of the affected part of the user, so as to call the operation parameters of each treatment unit for the user, wherein the operation parameters can be the operation time, the operation frequency, the operation temperature, the medicine dosage and the like of the treatment units, and the corresponding execution assignment is matched for each operation parameter, such as the specific duration of the operation time, the specific frequency of the operation frequency, the specific temperature of the operation temperature, the specific flow of the medicine dosage and the like, so as to control the treatment action execution of each treatment unit and carry out targeted treatment on the condition of the affected part of the user.
In some embodiments, analysis module 2 invokes the operating parameters of each treatment unit paired one-to-one with the execution assignment to generate a plurality of operating parameter sets; the blood flow dynamic monitoring part 3 acquires a plurality of blood parameters of a user in real time and uploads the blood parameters to the analysis module 2, such as blood flow velocity, pulse waveform, blood flow, vascular resistance, blood sample saturation and the like; the analysis module 2 acquires a plurality of blood parameters, respectively judges whether each blood parameter meets preset conditions, gives a corresponding judgment mark to each blood parameter data based on the judgment result of each blood parameter, and matches and selects an operation parameter set based on the set information formed by a plurality of judgment marks; the analysis module 2 controls the execution of the treatment actions of each treatment unit according to the matched selected operation parameter set.
A plurality of operation parameter sets may be pre-generated in the analysis module 2 according to clinical treatment experience, and these operation parameter sets may be capable of providing a treatment method with clinical treatment practice for the present rheumatoid arthritis treatment device, for example, according to clinical treatment experience, performing assignment of an operation parameter, i.e. a specific temperature value, of the operation temperature of the treatment unit is pre-set, and this operation parameter is combined with the operation parameter set of the associated performing assignment, so as to generate an operation parameter set.
After a plurality of operation parameter sets are pre-generated in the analysis module 2, the rheumatoid arthritis treatment device monitors the affected part condition of the user through the blood flow dynamic monitoring piece 3, and can match a treatment scheme with clinical treatment practice for the user according to the affected part condition of the user, so that the user obtains better treatment effect.
In order to illustrate the process of matching and selecting the operation parameter set by the analysis module 2, specifically, as shown in table 1, the analysis module 2 of the embodiment uses the operation temperature, the operation gear, the operation time and the operation frequency of the mild moxibustion massage module 6 as the operation parameters, uses the medicine type, the medicine delivery speed and the medicine dosage of the directional medicine penetrating module 5 as the operation parameters, and uses the operation time and the operation frequency of the far infrared module 4 as the operation parameters, and each operation parameter is configured with a corresponding execution assignment, for example, the execution assignment of the operation temperature is "40 ℃," 42 ℃, "45 ℃," so that the operation parameter set as shown in the control schemes 1 to 8 is generated in the analysis module 2 of the embodiment.
TABLE 1
As shown in fig. 4, the hemodynamic monitoring element 3 is capable of acquiring 5 blood parameters including blood flow velocity, spectral doppler waveform, blood flow, vascular resistance, and blood oxygen saturation in real time based on ultrasonic echo, and transmitting the acquired blood parameter data to the analysis module 2. The analysis module 2 obtains a plurality of blood parameters and makes the following decisions:
analyzing whether the blood flow velocity of a user is within a preset threshold range, and giving a first judgment mark based on an analysis result;
Analyzing whether the spectrum Doppler waveform of the user accords with a preset graph shape or not, and giving a second judgment mark based on an analysis structure;
analyzing whether the blood flow of the user is in a preset threshold range or not, and giving a third judgment mark based on an analysis result;
analyzing whether vascular resistance of a user is within a preset threshold range, and giving a fourth judgment mark based on an analysis result;
analyzing whether the blood oxygen saturation of the user is within a preset threshold range, and giving a fifth judgment mark based on an analysis result;
And according to the set information consisting of the first judgment mark, the second judgment mark, the third judgment mark, the fourth judgment mark and the fifth judgment mark, the corresponding operation parameter set can be matched, namely, the control schemes 1-8.
In this embodiment, the far infrared module 4, the directional drug permeable module 5, and the mild moxibustion massage module 6 are all treatment units that can be operated independently. In particular, the method comprises the steps of,
The far infrared module 4 comprises a far infrared radiation lamp 40 which can adjust the distance between the far infrared radiation lamp 40 and the body surface of a user, the far infrared radiation lamp 40 is rotatably connected to the shell 1, and a far infrared control module for adjusting the irradiation time and the irradiation frequency is arranged in the far infrared radiation lamp 40 and is connected with the analysis module 2.
The far infrared radiation lamp 40 has long wavelength infrared rays, can penetrate into the deep layer of the skin of the affected part, generates a warm effect, and generates various physiological effects on human tissues. For rheumatoid arthritis users, the far infrared treatment system has the functions of relieving pain and inflammation, improving joint mobility, promoting tissue repair and rehabilitation and the like.
In this embodiment, the directional drug permeable module 5 includes a drug permeable layer 50 that can be attached to the skin surface of the affected part, an electrode sheet (not shown in the figure) is wrapped in the drug permeable layer 50, and the drug permeable layer 50 is connected with a drug delivery component 51 for delivering a drug solution, and the electrode sheet and the drug delivery component 51 are both connected with the analysis module 2. The drug permeable layer 50 can be made of materials with better water absorbability such as sponge, and the drug liquid can be absorbed by the drug permeable layer 50 to directly contact with the affected part.
Specifically, the drug delivery module 51 includes a plurality of drug cartridges 510 for storing drug solutions, drug solution conduits (not shown) connected to the drug cartridges 510 in a one-to-one correspondence, and a transport power source (not shown) for drawing the drug solutions, the transport power source being connected to the analysis module 2, the plurality of drug solution conduits being collectively connected to the transport power source and connected to the drug permeable layer 50 via the transport power source.
The directional drug delivery module 5 is a treatment unit for delivering drugs directly to a target tissue or site, and for rheumatoid arthritis users, the directional drug delivery module 5 has the effects of improving treatment effects, reducing side effects, prolonging drug effects, and the like. Based on the control of the analysis module 2, the conveying power source can pertinently pump the liquid medicine in the medicine box 510 according to the condition of the affected part of the user, and provides a proper liquid medicine formula for the user. Through the drug permeable layer 50 and the electrode sheet, the drug solution stored in the drug box 510 can permeate to the drug permeable layer 50 through the drug solution catheter under the drive of the conveying power source, so that the drug is directly delivered to the affected area, the local treatment effect is realized, and the adverse effect on other healthy tissues is reduced to the greatest extent.
In this embodiment, the warm moxibustion massage module 6 includes a massage layer 60 which is pressed against the skin surface of the affected part, and a vibration element (not shown) for vibrating the massage layer 60 and a heating element (not shown) for heating the massage layer 60 are provided in the massage layer 60. Specifically, the massage layer 60 includes a plurality of balls 600, and each ball 600 has a vibration element and a heating element disposed therein, so that each ball 600 can vibrate and heat individually.
The warming moxibustion massage module 6 is a therapeutic system combining thermotherapy and massage therapy, and treats the user by using a specific heat source and vibration massage mode by configuring a vibration element and a heating element which can be simultaneously activated, aiming at relieving pain, improving blood circulation and relaxing tensed muscles.
In order to enable the treatment assembly to be convenient for a user to fix at the body surface of an affected part, the treatment assembly can be made of flexible materials to form a ring-shaped structure, so that a treatment ring body is formed. The user fixes the treatment ring body at the body surface position of the affected part through structures such as an elastic rope or a binding belt. Specifically, as shown in fig. 2 and 3, in this embodiment, the therapeutic assembly includes a flexible deformable base 7, the blood flow dynamic monitoring member 3 is disposed at one end of the base 7, the drug permeable layer 50 and the massage layer 60 are disposed at the same end of the base 7 around the blood flow dynamic monitoring member 3, and the drug permeable layer 50 and the massage layer 60 are spaced around the blood flow dynamic monitoring member 3, wherein,
In the area where the massage layer 60 is disposed, the massage layer 60 further includes a plurality of flexibly deformable support blocks 601, the support blocks 601 are disposed at one end of the base 7 where the hemodynamic monitoring element 3 is disposed, and protrude from the outer surface of the base 7, each of the balls 600 is respectively embedded in a corresponding support block 601, and the outer surface portion of the ball 600 extends out of the support block 601.
It should be noted that the supporting block 601 may be made of a flexible material such as silica gel. When the therapeutic ring is fixed at the affected part body surface position, the balls 600 are pressed against the skin of the affected part based on the convex design of the supporting block 601. In order to ensure that the drug permeable layer 50 and the blood flow dynamic monitoring can be attached to the skin of the affected part, the length of the supporting block 601 protruding from the outer surface of the substrate 7 can be designed according to the specification of the ball 600, so that the ball 600 is pressed on the skin of the affected part when the drug permeable layer 50 and the blood flow dynamic monitoring are attached to the skin of the affected part, and force meeting the massage requirement is applied to the affected part.
In the region where the drug-permeable layer 50 is arranged, a cavity 70 into which the drug-permeable layer 50 is embedded is provided in the base 7; at one end of the blood flow dynamic monitoring member 3 provided on the base 7, the cavity 70 is provided with an opening 700 communicating with the outside, and a stopper 701 disposed around the opening 700, the stopper 701 extending toward the center of the opening 700; the drug permeable layer 50 is embedded into the avoiding cavity 70 through the opening 700 and is abutted against the limiting block 701.
Based on the flexible deformation characteristic of the matrix 7, the therapeutic component can be attached to the skin of an affected part of a user, such as a hand joint and a foot joint, and as the drug permeable layer 50 and the massage layer 60 are arranged on the peripheral side of the blood flow dynamic monitoring piece 3, the region where the drug permeable layer 50 and the massage layer 60 are still the region where the blood parameters acquired by the blood flow dynamic monitoring piece 3 are disclosed, so that the therapeutic component can ensure the matched operation parameter set according to the blood parameters acquired by the blood flow dynamic monitoring piece 3, and has a targeted therapeutic effect on the affected part of the user.
Taking the blood parameters shown in table 1 as an example, the following describes the operation of the rheumatoid arthritis therapeutic device as follows:
When the rheumatoid arthritis therapeutic device works, a user can fix the basal body 7 on an affected part through an elastic rope or a binding belt connected to the basal body 7, and make the basal body 7 be attached to the skin of the affected part, so that the blood flow dynamic monitoring piece 3 is attached to the body surface of the affected part, and at the moment, the massage layer 60 and the drug permeable layer 50 are attached to the body surface of the affected part at the same time and are positioned on the periphery side of the blood flow dynamic monitoring piece 3.
The blood flow dynamic monitoring piece 3 generates voltage through a chemical electrode of the blood flow dynamic monitoring piece, and applies voltage to the ultrasonic transducer, so that the blood flow dynamic monitoring piece 3 can acquire 5 blood parameters of blood flow speed, spectrum Doppler waveform, blood flow, vascular resistance and blood oxygen saturation in real time in a non-invasive mode, and the acquired blood parameters are transmitted to the analysis module 2.
As shown in the figure, the analysis module 2 sequentially determines whether 5 blood parameters of blood flow velocity, spectral doppler waveform, blood flow, vascular resistance, and blood oxygen saturation meet preset conditions, and matches a corresponding operation parameter set, i.e., any one of the control schemes 1 to 8, according to the determination results of the 5 blood parameters.
According to the matched control scheme, the analysis module 2 controls the actions of the far infrared module 4, the directional drug permeation module 5 and the warm moxibustion massage module 6, wherein,
The far infrared module 4 manually adjusts the distance between the far infrared radiation lamp 40 and the affected part of the user, continuously irradiates the affected part of the user by using the far infrared radiation lamp 40, and provides far infrared treatment for the user;
the directional drug permeation module 5 is controlled by the analysis module 2, extracts the drug liquid in the corresponding drug box 510 through the drug liquid guide pipe by a conveying power source, conveys the extracted drug liquid to the drug permeation layer 50, and simultaneously, the analysis module 2 controls the electrode plates in the drug permeation layer 50 to work so as to provide directional drug permeation treatment for a user;
the moxibustion massage module 6 is controlled by the analysis module 2, and respectively adjusts the vibration frequency, the vibration amplitude and the temperature of each ball 600 by the vibration element and the heating element arranged in each ball 600, so that the balls 600 compress and squeeze the affected parts of the user, and moxibustion massage treatment is provided for the user.
It should be noted that, in the same therapeutic assembly, the connection circuits connected to the blood flow dynamic monitoring element 3, the directional drug permeation module 5, and the warm moxibustion massage module 6 may be connected in parallel to the drug delivery pipeline connected to the drug permeation layer 50, but the waterproof isolation between the connection circuits and the drug delivery pipeline needs to be ensured.
In summary, the embodiment of the invention provides a rheumatoid arthritis treatment device, which is used for matching the working states of all treatment units in a targeted manner according to the blood flow condition of an affected part of a user, and matching a treatment scheme with targeted clinical treatment practice for the user, so that the user obtains a better treatment effect; in addition, the blood flow dynamic monitoring piece 3 of the rheumatoid arthritis treatment device monitors the blood flow condition of the affected part of the user in a non-invasive manner, the limb of the user can freely move in the treatment process, the invasive damage to the user can not be caused, and the use is more convenient; in addition, the rheumatoid arthritis treatment device combines the far-infrared module 4, the directional drug permeation module 5 and the warm moxibustion massage module 6 to apply comprehensive treatment to the affected part of the user in a multi-mode, so that the treatment effect is more comprehensive.
The foregoing is merely a preferred embodiment of the present invention, and it should be noted that modifications and substitutions can be made by those skilled in the art without departing from the technical principles of the present invention, and these modifications and substitutions should also be considered as being within the scope of the present invention.
Claims (9)
1. A rheumatoid arthritis therapeutic device, comprising an analysis module and a therapeutic assembly; wherein,
The treatment assembly includes a plurality of independently operated treatment units and a hemodynamic monitoring element,
Each treatment unit is connected with the analysis module and executes treatment action based on the operation parameters set by the analysis module;
The blood flow dynamic monitoring piece is connected with the analysis module and is attached to the body surface of the user, so that blood parameters of the user are obtained in a non-invasive manner in real time;
the operation parameter set of each treatment unit is pre-constructed in the analysis module, the operation parameters associated with the treatment units are set in the operation parameter set of each treatment unit, and a plurality of execution assignment values are pre-set for the operation parameters;
the analysis module receives the user blood parameters acquired by the blood flow dynamic monitoring part in real time, and according to the received user blood parameters, the analysis module invokes the operation parameters of each treatment unit in the operation parameter set, matches corresponding execution assignment for each operation parameter, and controls the action execution of each treatment unit according to the matched execution assignment operation parameters.
2. The rheumatoid arthritis therapeutic apparatus according to claim 1,
The blood flow dynamic monitoring part acquires a plurality of blood parameters of a user in real time and uploads the blood parameters to the analysis module;
The analysis module is used for calling the operation parameters of each treatment unit and performing assignment one-to-one pairing to generate a plurality of operation parameter sets; the analysis module acquires a plurality of blood parameters, respectively judges whether each blood parameter meets preset conditions, gives corresponding judgment marks to each blood parameter data based on the judgment result of each blood parameter, and matches and selects corresponding operation parameter sets based on the set information formed by the plurality of judgment marks;
The analysis module controls the treatment action of each treatment unit to be executed according to the matched and selected operation parameter set.
3. The rheumatoid arthritis therapeutic device according to claim 1 or 2, wherein the therapeutic unit is a far-infrared module, the far-infrared module comprises a far-infrared radiation lamp capable of adjusting the distance between the far-infrared radiation lamp and the body surface of the user, a far-infrared control module for adjusting the irradiation time and the irradiation frequency is arranged in the far-infrared radiation lamp, and the far-infrared control module is connected with the analysis module.
4. The rheumatoid arthritis treatment device according to claim 1 or 2, wherein the treatment unit is a directional drug permeation module and a warm moxibustion massage module, wherein,
The directional drug permeation module comprises a drug permeation layer which can be attached to the surface layer of the skin of an affected part, an electrode plate is wrapped in the drug permeation layer, the drug permeation layer is connected with a drug delivery component for delivering liquid medicine, and the electrode plate and the drug delivery component are connected with the analysis module;
The warm moxibustion massage module comprises a massage layer which can be pressed on the surface layer of the skin of an affected part, and a vibration element for vibrating the massage layer and a heating element for heating the massage layer are arranged in the massage layer.
5. The rheumatoid arthritis therapeutic device according to claim 4, wherein the drug delivery module comprises a plurality of drug cartridges for storing drug solutions, drug solution conduits connected in one-to-one correspondence with the drug cartridges, a delivery power source for extracting the drug solutions, the delivery power source being connected to the analysis module, a plurality of the drug solution conduits being collectively connected to the delivery power source and connected to the drug permeable layer via the delivery power source.
6. The rheumatoid arthritis treatment device of claim 4, wherein the treatment assembly comprises a flexibly deformable base, the hemodynamic monitoring element is disposed at one end of the base, the drug permeable layer and the massage layer are disposed at the same end of the base around the hemodynamic monitoring element, and the drug permeable layer and the massage layer are spaced apart around the hemodynamic monitoring element.
7. The rheumatoid arthritis therapeutic device according to claim 6, wherein the massage layer comprises a plurality of balls, the vibration element and the heating element being provided in each of the balls.
8. The rheumatoid arthritis therapeutic device according to claim 7, wherein the massage layer further comprises a plurality of flexibly deformable support blocks provided at one end of the base body where the hemodynamic monitoring element is arranged and protruding from an outer surface of the base body, each of the balls is respectively embedded in the corresponding support block, and an outer surface portion of the ball protrudes out of the support block.
9. The rheumatoid arthritis therapeutic device according to claim 6, wherein a cavity for embedding the drug permeable layer is provided in the base; the blood flow dynamic monitoring device comprises a basal body, a blood flow dynamic monitoring piece, a cavity and a limiting block, wherein the basal body is provided with one end of the blood flow dynamic monitoring piece, the cavity is provided with an opening communicated with the outside, and the limiting block is arranged around the opening and extends towards the center of the opening; the drug permeable layer is embedded into the avoidance cavity through the opening and is abutted to the limiting block.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410241293.6A CN118121465A (en) | 2024-03-04 | 2024-03-04 | Rheumatoid arthritis treatment device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410241293.6A CN118121465A (en) | 2024-03-04 | 2024-03-04 | Rheumatoid arthritis treatment device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN118121465A true CN118121465A (en) | 2024-06-04 |
Family
ID=91238771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410241293.6A Pending CN118121465A (en) | 2024-03-04 | 2024-03-04 | Rheumatoid arthritis treatment device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN118121465A (en) |
-
2024
- 2024-03-04 CN CN202410241293.6A patent/CN118121465A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20200171329A1 (en) | Device and method to treat vaginal atrophy | |
| US11433259B2 (en) | Internal organ, injury and pain treatment | |
| US20230310904A1 (en) | Extracorporeal therapeutic ultrasound for promoting angiogenesis | |
| JP5235197B2 (en) | Device for treating cellulite and fat mass | |
| CN1756522A (en) | Device for applying a pulsating pressure to a local region of the body and applications thereof | |
| US11951335B2 (en) | Internal organ, injury and pain, pulmonary condition and adipose tissue treatment | |
| KR101007197B1 (en) | Apparatus for generating ultrasonics wave using piezoelectric sensor as band type | |
| US20150073311A1 (en) | Method and device for treating pathological conditions associated with bone and musculoskeletal environments | |
| CN217661124U (en) | Health care device | |
| US20090171251A1 (en) | Ultrasound treatment of adipose tissue with vacuum feature | |
| CN118121465A (en) | Rheumatoid arthritis treatment device | |
| KR20110031530A (en) | Ultrasound and RF high frequency integrated fusion system for drug absorption promotion | |
| WO2020076003A1 (en) | Portable ultrasonic stimulator | |
| KR200186494Y1 (en) | An ultrasonic bathtub for foot using a chinese medicine | |
| US20230093814A1 (en) | Extracorporeal therapeutic ultrasound for promoting angiogenesis | |
| KR20130019971A (en) | Method for heating local area of body by ultrasound and stimulator transmitting ultrasound | |
| KR100365024B1 (en) | An ultrasonic bathtub for foot using a chinese medicine | |
| KR20030014548A (en) | Ultrasonic physical therapy device using herbal medicine | |
| US20090171250A1 (en) | Ultrasound treatment of adipose tissue with fluid injection | |
| KR20200077863A (en) | Mobile ultrasonic stimulation apparatus | |
| CN220735953U (en) | Ultrasonic drug-permeable hydrotherapy instrument | |
| KR20190106407A (en) | Multi-function ultrasonic physical treatment device | |
| US20230390553A1 (en) | Multifunctional beauty device and handpiece of beauty instrument | |
| KR200474912Y1 (en) | Ultrasonic therapy device for joints | |
| IL277084A (en) | Pulmonary condition treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination |